709 related articles for article (PubMed ID: 32961081)
1. Impact of COVID-19 on vaccination programs: adverse or positive?
Ali I
Hum Vaccin Immunother; 2020 Nov; 16(11):2594-2600. PubMed ID: 32961081
[TBL] [Abstract][Full Text] [Related]
2. Latin American forum on immunization services during the COVID-19 pandemic.
Ávila-Agüero ML; Ospina-Henao S; Pirez MC; Gentile Á; Araya S; Brea J; Mendoza L; Falleiros-Arlant LH
Expert Rev Vaccines; 2021 Mar; 20(3):231-234. PubMed ID: 33554682
[No Abstract] [Full Text] [Related]
3. Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries.
Bello IM; Lebo E; Shibeshi ME; Akpan GU; Chakauya J; Masresha BG; Daniel F
Pan Afr Med J; 2021; 38():164. PubMed ID: 33995771
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 outbreak: a potential threat to routine vaccination programme activities in Nigeria.
Ogundele OA; Omotoso AA; Fagbemi AT
Hum Vaccin Immunother; 2021 Mar; 17(3):661-663. PubMed ID: 32991237
[TBL] [Abstract][Full Text] [Related]
5. Impact of social distancing on incidence of vaccine-preventable diseases, South Korea.
Yun HE; Ryu BY; Choe YJ
J Med Virol; 2021 Mar; 93(3):1814-1816. PubMed ID: 33079384
[TBL] [Abstract][Full Text] [Related]
6. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
Ho LL; Gurung S; Mirza I; Nicolas HD; Steulet C; Burman AL; Danovaro-Holliday MC; Sodha SV; Kretsinger K
Int J Infect Dis; 2022 Jun; 119():201-209. PubMed ID: 35398300
[TBL] [Abstract][Full Text] [Related]
7. Implications of COVID-19 and "super floods" for routine vaccination in Pakistan: The reemergence of vaccine preventable-diseases such as polio and measles.
Ali I; Hamid S
Hum Vaccin Immunother; 2022 Dec; 18(7):2154099. PubMed ID: 36573023
[TBL] [Abstract][Full Text] [Related]
8. The Role of Law and Ethics in Recent Preparedness and Response for Vaccine-Preventable Illness.
Silverman RD
Public Health Rep; 2020; 135(6):851-855. PubMed ID: 32791033
[No Abstract] [Full Text] [Related]
9. Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories.
Shet A; Carr K; Danovaro-Holliday MC; Sodha SV; Prosperi C; Wunderlich J; Wonodi C; Reynolds HW; Mirza I; Gacic-Dobo M; O'Brien KL; Lindstrand A
Lancet Glob Health; 2022 Feb; 10(2):e186-e194. PubMed ID: 34951973
[TBL] [Abstract][Full Text] [Related]
10. Impact of COVID-19 pandemic on the utilization of routine immunization services in Lebanon.
Mansour Z; Arab J; Said R; Rady A; Hamadeh R; Gerbaka B; Bizri AR
PLoS One; 2021; 16(2):e0246951. PubMed ID: 33596271
[TBL] [Abstract][Full Text] [Related]
11. Emergence of Vaccine-Preventable Diseases: The Perfect Storm of Hesitancy, Refusal, a Pandemic, and War.
McGrath E
Pediatr Ann; 2022 Nov; 51(11):e426-e430. PubMed ID: 36343179
[TBL] [Abstract][Full Text] [Related]
12. Knowledge and Behaviours towards Immunisation Programmes: Vaccine Hesitancy during the COVID-19 Pandemic Era.
Dettori M; Arghittu A; Castiglia P
Int J Environ Res Public Health; 2022 Apr; 19(7):. PubMed ID: 35410045
[TBL] [Abstract][Full Text] [Related]
13. Entangled epidemics: tackling vaccine-preventable diseases in the era of frequent epidemics in Africa.
Kouamou V; Inzaule S
Pan Afr Med J; 2023; 46():32. PubMed ID: 38145199
[TBL] [Abstract][Full Text] [Related]
14. Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020.
Middeldorp M; van Lier A; van der Maas N; Veldhuijzen I; Freudenburg W; van Sorge NM; Sanders EAM; Knol MJ; de Melker HE
Vaccine; 2021 Feb; 39(7):1039-1043. PubMed ID: 33478793
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.
Dhama K; Sharun K; Tiwari R; Dhawan M; Emran TB; Rabaan AA; Alhumaid S
Hum Vaccin Immunother; 2021 Oct; 17(10):3495-3499. PubMed ID: 34191680
[TBL] [Abstract][Full Text] [Related]
16. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
Oh KB; Doherty TM; Vetter V; Bonanni P
Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
[TBL] [Abstract][Full Text] [Related]
17. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017.
Dong Y; Wang L; Burgner DP; Miller JE; Song Y; Ren X; Li Z; Xing Y; Ma J; Sawyer SM; Patton GC
BMJ; 2020 Apr; 369():m1043. PubMed ID: 32241761
[TBL] [Abstract][Full Text] [Related]
18. The need for vaccination in adults with chronic (noncommunicable) diseases in India - lessons from around the world.
Vora A; Di Pasquale A; Kolhapure S; Agrawal A; Agrawal S
Hum Vaccin Immunother; 2022 Nov; 18(5):2052544. PubMed ID: 35416747
[TBL] [Abstract][Full Text] [Related]
19. The Risk of Resurgence in Vaccine-Preventable Infections Due to Coronavirus Disease 2019-Related Gaps in Immunization.
Feldman AG; O'Leary ST; Danziger-Isakov L
Clin Infect Dis; 2021 Nov; 73(10):1920-1923. PubMed ID: 33580243
[TBL] [Abstract][Full Text] [Related]
20. Effect of COVID-19 restrictions and border closures on vaccine preventable diseases in Victoria, Australia, 2020-2021.
Bhatt P; Strachan J; Easton M; Franklin L; Drewett G
Commun Dis Intell (2018); 2022 May; 46():. PubMed ID: 35591751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
